Save 20% on Press Releases and More with NNW Prime! Click to View Details
FridayJan 29, 2021 11:20 am

Robots Don’t Get Sick: Security Guard Market Survives the COVID-19 Storm

The coronavirus pandemic that has been raging on for over a year now has impacted every industry in some form. For security companies, they have quietly stepped up to the front line, assisting local governments and communities to cope with the widespread outbreak. Whether it has meant helping with safe patient transfer, securing isolated areas, or protecting travel routes, those in the security industry have made the list of mostly overlooked heroes fighting the resilient virus. Many stores increased various security measures to ensure that customers and employees were safe at all times. Add it up and it speaks to…

Continue Reading

FridayJan 29, 2021 11:00 am

Hollywall Entertainment Inc. (HWAL) Is ‘One to Watch’

Hollywall Entertainment Inc. is currently working on expanding the company through the acquisition of businesses within its targeted industries Hollywall subsidiaries are already working on multiple projects, most notably its HWDC subsidiary’s focus on the smart city concept leveraging 5G technology, internet of things and other innovative technologies The global 5G market is estimated to reach $414.5 billion by 2027, achieving a CAGR of 43.9% In December 2020, the company entered an agreement to acquire Omnipoint Technology, and it has launched HW Vision, a unique provider of state-of-the-art telecommunications services. The music catalog licenses held by Hollywall Music and the…

Continue Reading

ThursdayJan 28, 2021 3:52 pm

United Medical Equipment Business Solutions Network Inc. Breaks Barriers to Medication Adherence

Flaws in the U.S. health-care system revealed during COVID-19 pandemic Lack of medication adherence can lead to serious issues, including worsening of disease, possible death and increased costs United Medical offers solutions for poor patient-physician communication and inadequate medication knowledge The COVID-19 pandemic has revealed flaws in the U.S. health-care system, including flaws that require patients and caregivers to take a more active and educated role. United Medical Equipment Business Solutions Network (“UME”) provides reliable resources and solutions to help providers work more proficiently, health-care systems work smarter, and patients live healthier lives. “This pandemic is a watershed moment in…

Continue Reading

ThursdayJan 28, 2021 3:39 pm

HYB Holding Corp. (HYBG) Is ‘One to Watch’

HYB Holding Corp.’s subsidiary, Mediscan Inc., offers technology that can turn 2D images from a portable ultrasound machine into digital 3D images to provide better diagnosis and more accurate internal trauma views Mediscan’s technology has multiple applications in lung, cardiac and musculoskeletal imaging and related applications A portable ultrasound scanner equipped with the Mediscan application can help detect and diagnose lung and cardiac tissue damage in COVID-19 patients, who cannot undergo regular imaging procedures while contagious Mediscan recently filed a provisional patent application with the United States Patent and Trademark Office for a System Method, Apparatus, and Computer Program Product…

Continue Reading

ThursdayJan 28, 2021 3:23 pm

CannAssist International Corp. (CNSC) Addresses CBD Absorption Issues with Proprietary CiBiDinol Technology

CBD products in oil-based form have compromised bioavailability, according to experts CNSC's Xceptol CBD products created with proprietary CiBiDinol technology that addresses absorption issues for superior efficacy Third-party Xceptol testing shows 300% increased gut absorption, 400% increased skin penetration when compared to mainstream CBD oil products Growing in popularity in a myriad of markets, cannabidiol (“CBD”) is a phytocannabinoid that can mimic natural endocannabinoids in the human body for various therapeutic effects. Growing awareness around the use of oil-based CBD has led to skyrocketing popularity among the mainstream public despite bioavailability concerns among healthcare professionals and doctors (https://nnw.fm/6GGZh). CannAssist International…

Continue Reading

ThursdayJan 28, 2021 2:17 pm

Predictive Oncology (NASDAQ: POAI) Subsidiary Working to Individualize, Improve Ovarian Cancer Treatment Options

Ovarian cancer is a leading cause of death, causes more death than any other female reproductive system cancer POAI’s Helomics dedicated to improving clinical decision making for ovarian cancer patients Helomics has pioneered testing of drugs on patients’ own tumors to help oncologists individualize treatment options According to the American Cancer Society, an estimated 21,750 women received a new diagnosis of ovarian cancer this year, and almost 14,000 women will die from the disease (https://nnw.fm/sWFHc). Those numbers make ovarian cancer the fifth-leading cause of cancer deaths in women; ovarian cancer causes more deaths than any other cancer of the female…

Continue Reading

ThursdayJan 28, 2021 11:46 am

Pure Extracts Technologies Corp. (CSE: PULL) (OTC: PRXTF) (XFRA: A2QJAJ) Increases Private Placement, Begins Trading on OTC Market

Pure Extracts upsizes private placement to total 16,900,000 special warrants at price of $0.505. PULL also received approval from OTC Markets, is trading on OTC Market under ticker symbol PRXTF. Trading under new OTC ticker is “major step forward,” says Company CEO. Pure Extracts Technologies (CSE PULL) (OTC: PRXTF) (XFRA: A2QJAJ), a plant-based extraction company, has increased its non-brokered private placement offering of special warrants; the original offering was announced on Dec. 16, 2020. The company also received approval from OTC Markets and is now trading on the OTC Market under the ticker symbol PRXTF. The Company observed that the…

Continue Reading

ThursdayJan 28, 2021 9:00 am

Trade Volume Explodes as Retail Traders Make Their Mark

NetworkNewsWire Editorial Coverage: Only three weeks into the new year, and stock trading volumes are “through the roof,” reports a Jan. 22 CNBC article , titled “Trading Volume Is Up from 2020′S Breakneck Pace as Retail Investors Jump In.” The article continues: “It’s not just equity prices that are hitting new highs in 2021. Trading volumes for stocks and options are at records as well. Much of it is being driven by retail investors, who are continuing the high level of engagement that began in 2020.” January volumes are up 92% from last year and up 33% just since December.…

Continue Reading

WednesdayJan 27, 2021 4:03 pm

FinovateEurope Conference Keeps Pace with Essential Fintech Innovation as Pandemic Continues

What: FinovateEurope is a virtual gathering of fintech innovators and financial institutions focused on the European continent When: March 23-25, 2021 scheduled for the Central European Time zone, but with 24-hour live and on-demand access to accommodate a global attendance More than 50 expert speakers and over 25 product demos, as well as over a thousand senior decision makers from fintech-related businesses A diversity of networking opportunities, whether through real-time Q&A sessions, one-on-one meetings, virtual coffee chats and small group get-togethers The Internet revolution that occurred a generation ago made networking the lifeblood of today’s technology and gave global economies…

Continue Reading

WednesdayJan 27, 2021 3:47 pm

CNS Pharmaceuticals, Inc. (NASDAQ: CNSP) Discusses Product Pipeline, Clinical Trial Plans, at H.C. Wainwright Bioconnect 2021 Virtual Conference

Company will initiate a Phase II adult trial for Berubicin this year focused on patients with glioblastoma multiforme WPD, a CNS sub-license partner, will be commencing a parallel Phase II adult trial and the first-ever pediatric Berubicin trial Additional clinical trials are in the pipeline, including one for the company’s newest drug candidate, WP1244, and its effects on central nervous system tumors Biopharmaceutical company CNS Pharmaceuticals (NASDAQ: CNSP) recently took part in the H.C. Wainwright Bioconnect 2021 Virtual Conference, which took place January 11-14, 2021. CNS’s CEO John Climaco gave a presentation at the event, discussing how the clinical-stage biopharmaceutical…

Continue Reading

NetworkNewsWire Currently Accepts

Bitcoin

Bitcoin

Bitcoin Cash

Bitcoin Cash

Doge Coin

Dogecoin

Ethereum

Ethereum

Litecoin

Litecoin

USD Coin

USD Coin

Contact us: 512.354.7000